Abbott India Ltd PE Ratio

Abbott India PE Ratio

Image

Abbott India Ltd

NSE: ABBOTINDIA

PE

36.6

Last updated on: Feb 21, 2026

Key Highlights

  • The P/E Ratio of Abbott India Ltd is 36.6 as of 21 Feb 9.00 AM The P/E Ratio of Abbott India Ltd changed from 46.1 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 0.04% over 5 years The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 19.0. The PE Ratio of IT - Software industry is 27.7. The PE Ratio of Pharmaceuticals industry is 32.3. The PE Ratio of Retail industry is 123.0. The PE Ratio of Textiles industry is 54.9 in 2025 .

Historical P/E Ratio of Abbott India Ltd

No data available

Company Fundamentals for Abbott India Ltd

Image

Abbott India Ltd

NSE: ABBOTINDIA

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Abbott India Ltd

1M

1Y

3Y

5Y

Monitoring Abbott India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 202626263.35
19 Feb 202626389.45
18 Feb 202626466.6
17 Feb 202626501.35
16 Feb 202626323.15
13 Feb 202626469.95
12 Feb 202626684.9
11 Feb 202626894.05
10 Feb 202627314.7
09 Feb 202627478.35

SWOT Analysis Of Abbott India Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Abbott India Ltd

Asset Value vs Market Value of Abbott India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of Abbott India Ltd

X

PE Ratio of Top Sectors

Historical Market Cap of Abbott India Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Abbott India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Abbott India Ltd

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Limited was originally incorporated on August 22, 1944 as Boots Pure Drug Company (India) Limited.
  • The company name was changed to 'The Boots Company (India) Limited' on November 1, 1971, thereafter to Boots Pharmaceuticals Limited on January 1, 1991.
  • In October, 1995 the name was changed to Knoll Pharmaceuticals Limited, and in July, 2002, they got their present name 'Abbott India Limited'. Company is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.

Abbott India Ltd News Hub

Abbott India standalone net profit rises 13.01% in the June 2024 quarter

Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 as against

Read more

08 Aug 24

Sensex, Nifty hit new life highs; auto shares in demand

The key equity indices further extended gains and hit fresh record highs in mid-morning trade. The N

Read more

20 Sept 24

Abbott India joins hand with Takeda Pharma to launch Vonoprazan tablets in India

Vonoprazan (PCAB or potassium competitive acid blocker) addresses severe acid related disorders like

Read more

20 Sept 24

Abbott India director resigns

Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Vaccines and

Read more

18 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions